|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street SW |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lucia DiVenere, Senior Director of Government Affairs |
Date | 01/20/2011 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Public health Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Agency for Healthcare Research and Quality (AHRQ) for biomedical research; Comprehensive Sexuality Education funding (general); Affordable birth control; International family planning; Indian Health Services (IHS); Violence Against Women Programs; Office of Adolescent Health.
Maternal Mortality Reviews (CDC); Electronic Birth and Death Records (CDC); National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment Prevention (HHS); Comparitive Effectiveness Research (AHRQ); Department of Defense (DOD) Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Research (NIH); Title V Block Grant (HRSA); STD Prevention (CDC).
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Centers For Medicare and Medicaid Services (CMS), Indian Health Service, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Josef |
Weissfeld |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR.463,The Prevention First Act; Comprehensive Sexuality Education funding (general), National HIV/AIDS Strategy (general); H.R. 3312 H.R. 3652; S. 3737, CARE Act; H.R. 5354, GEDI Act;Sudden unexpected infant deaths (general); Postpartum Depression (general); Emergency Contraception (general); Pre-existing condition exclusion (general); Gender rating (general).
Preventive Care (general); Domestic Violence(general); Prescription Drug Coverage (general); Comparative Effectiveness Research (general); Medicaid SCHIP Coverage and Reimbursement; HIV Screening (general); H.R. 2941Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); HR 4386, S. 2904 Emergency Contraception in the Military; Direct Access to Ob-Gyns (general); S. 1742, H.R. 4235 Women's Hospitals Education Equity; National HIV/AIDS Strategy Steps; H.R. 3854 Small Business Financing and Investment Act of 2009; H.R. 4216 Personal Health Record Act of 2009; Abortion (general); H.R. 4872 Health Care and Reconciliation Act of 2010; Health IT (general); Birth Defects(general);Birth Centers (general);Prematurity(general);Obesity (general);Disparities (general);Smoking cessation (general); Prevention & Public Health Trust Fund(general); S.1445 and H.R.3212, Stillbirth and Suid Prevention Education, Awareness Act of 2009,H.R.5462 and S.3479, Birth Defects, Prevention Risk Reduction, Awareness Act of 2010; USDA Dietary Guidelines Advisory Committee Report; H.R. 5690, The Meaningful End to Defensive Medicine and Aimless Lawsuits; S. 422; H.R. 3470, Newborn Act; S. 3906, Preemie Act; H.R. 6437, Improve Maternity Care Quality Act 2010; H.R. 1995/ S. 844, Eliminating Diabetes Disparities; S. 3307 Healthy Hunger-Free Kids Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Josef |
Weissfeld |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Sustainable Growth Rate Formula Reform (general); Independent Payment Advisory Board (general); ; FMAP (general);Imaging Accreditation H.R. 4213; H.R. 5618; Medicaid Primary Care Payment (General);H.R.4994, Medicare and Medicaid Extenders Act 2010; H.R. 4985, Medicare Decisions Accountability Act of 2010.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Josef |
Weissfeld |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |